Putting Prevention First - the national strategy for assessing cardiovascular risk in everyone between the ages of 40 and 74 years - is here to stay, regardless of any changes in the NHS. This strategy is based on assessing a patient's individual risk of cardiovascular disease and, where this risk is significant, offering them measures to reduce this risk. In this article, we look at how to achieve a key step in this process: explaining the complex concept of absolute cardiovascular risk to patients so they understand what's at stake when deciding whether or not to take their statin or antihypertensive.
Weight loss (bariatric) surgery is becoming increasingly common as the obesity epidemic continues to flourish, and recent NICE guidelines have supported this approach. In this article, we review the procedures used in bariatric surgery, the impact on patients' cardiovascular risk and type 2 diabetes, what the guidelines recommend and the long-term care of patients who have undergone this type of surgery.
The impact of female hormones on cardiovascular risk is a hot issue. Many nurses working in the NHS, including in general practice, are aged 50 or older. This means that there is a strong possibility that some of us may be experiencing menopausal symptoms, along with our patients. In this article, we look at the use of hormonal therapies at the time of the menopause, with particular reference to cardiovascular risk. We will also touch on the use of oral contraception and associated cardiovascular factors.
Results from the ADVANCE trial support the need for intensive efforts to promote smoking cessation in people with diabetes. As well as increased risks to cardiovascular health in all diabetic patients who smoke, women with diabetes who smoke appear to be at a greater risk of coronary events than men.
Women with diabetes appear to be at a higher risk of developing vascular dementia than men, according to the results of a major systematic review including >2 million people published in Diabetes Care.
Male hypogonadism—also known as testosterone deficiency syndrome—occurs when the testes no longer produce enough testosterone. Testosterone deficiency may be an important factor in increasing a man's cardiovascular risk. However, the symptoms are often overlooked in older men, both by primary healthcare professionals and by patients themselves.
The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event. Don't miss out, last few places available
The long-awaited Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3) were issued at the end of March.
A 4-year observational study reveals significant results about the effectiveness of the NHS Health Check. The study reviewed data from 214,295 people in England who attended an NHS Health Check and compared these findings against 1.4 million people who had not yet been offered or taken up their checks.
New data show that after 3 years’ treatment with liraglutide, adults with obesity or who are overweight with comorbidities lost more weight, reduced blood pressure, triglycerides and cholesterol level compared with placebo.